GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Short-term investments

GelStat (GelStat) Short-term investments


View and export this data going back to 1996. Start your Free Trial

What is GelStat Short-term investments?

Short-term investments only applies to insurance companies.


GelStat (GelStat) Business Description

Traded in Other Exchanges
N/A
Address
333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Executives
Adrian Graham Goldfarb director 7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller director, officer: Chief Financial Officer
Garry N Lowenthal officer: Chief Financial Officer 2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421